The impact of COVID-19 pandemic on anxiety levels among patients who have to go to the hospital due to chronic illnesses: A prospective study
Corresponding Author
Pervin Ozkan Kurtgoz
Department of Internal Medicine, Division of Nephrology, University of Health Sciences, Konya City Hospital, Konya, Turkey
Correspondence
Pervin Ozkan Kurtgoz, Department of Internal Medicine, Division of Nephrology, University of Health Sciences, Konya City Hospital, Karatay/Konya 42020, Turkey.
Email: [email protected]
Search for more papers by this authorFatih Sackan
Department of Internal Medicine, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorIrem Oner
Department of Internal Medicine, Division of Oncology, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorOzlem Bilgin
Department of Internal Medicine, Division of Nephrology, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorDeniz Ozdemir
Department of Internal Medicine, Division of Oncology, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorSuleyman Karakose
Department of Internal Medicine, Division of Nephrology, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorMehmet Ali Eryılmaz
Department of General Surgery, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorIbrahim Guney
Department of Internal Medicine, Division of Nephrology, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorMuhammet Cemal Kızılarslanoglu
Department of Internal Medicine, Division of Geriatrics, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorCorresponding Author
Pervin Ozkan Kurtgoz
Department of Internal Medicine, Division of Nephrology, University of Health Sciences, Konya City Hospital, Konya, Turkey
Correspondence
Pervin Ozkan Kurtgoz, Department of Internal Medicine, Division of Nephrology, University of Health Sciences, Konya City Hospital, Karatay/Konya 42020, Turkey.
Email: [email protected]
Search for more papers by this authorFatih Sackan
Department of Internal Medicine, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorIrem Oner
Department of Internal Medicine, Division of Oncology, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorOzlem Bilgin
Department of Internal Medicine, Division of Nephrology, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorDeniz Ozdemir
Department of Internal Medicine, Division of Oncology, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorSuleyman Karakose
Department of Internal Medicine, Division of Nephrology, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorMehmet Ali Eryılmaz
Department of General Surgery, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorIbrahim Guney
Department of Internal Medicine, Division of Nephrology, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorMuhammet Cemal Kızılarslanoglu
Department of Internal Medicine, Division of Geriatrics, University of Health Sciences, Konya City Hospital, Konya, Turkey
Search for more papers by this authorAbstract
Introduction
Cancer and hemodialysis (HD) patients are at high risk for COVID-19. In our study, we aimed to evaluate the effect of pandemic on anxiety in these patients.
Methods
One hundred and six oncology and 97 HD patients participated in the study. Anxiety levels were assessed by using the Beck Anxiety Inventory (BAI) and State-Trait Anxiety Inventory (STAI). At the end of 8-month follow-up, these questionnaires were re-administered.
Results
During this period, 38 patients (38/203; 18.7%) had COVID-19 infection. Twenty-three patients (23/203; 11.3%) died due to COVID-19 and/or other causes. One hundred and thirteen of the remaining patients were participated in the second questionnaire. Having COVID-19 was not the independent factor for changes in STAI, and BAI scores in any regression models.
Conclusion
Having COVID-19 does not affect the increased anxiety levels in HD and oncology patients. The effect of the pandemic may have remained in the background, as these patients have more concerns about their own diseases.
CONFLICT OF INTEREST STATEMENT
The authors declare that they have no conflict of interest.
REFERENCES
- 1Sharma K, Koirala A, Nicolopoulos K, Chiu C, Wood N, Britton PN. Vaccines for COVID-19: where do we stand in 2021? Paediatr Respir Rev. 2021; 39: 22–31.
- 2Gupta R, Dhamija RK. Covıd-19: social distancing or social isolation? BMJ. 2020; 369:m2399. https://doi.org/10.1136/bmj.m2399
- 3Ibernon M, Bueno I, Rodríguez-Farré N, Ruiz P, Sánchez A, Massó E, et al. The impact of COVID-19 in hemodialysis patients: experience in a hospital dialysis unit. Hemodial Int. 2021; 25(2): 205–13. https://doi.org/10.1111/hdi.12905
- 4Liu C, Zhao Y, Okwan-Duodu D, Basho R, Cui X. COVID-19 in cancer patients: risk, clinical features, and management. Cancer Biol Med. 2020; 17: 519–27.
- 5Murtagh FE, mAddington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007; 14: 82–99.
- 6Pitman A, Suleman S, Hyde N, Hodgkiss A. Depression and anxiety in patients with cancer. BMJ. 2018; 361:k1415. https://doi.org/10.1136/bmj.k1415
- 7Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988; 56: 893–7.
- 8Ulusoy M, Sahin N, Erkmen H. The Beck anxiety inventory: psychometric properties. J Cogn Psychother. 1998; 12: 163–72.
- 9Spielberger CD, Vagg PR. Psychometric properties of the STAI: a reply to Ramanaiah, Franzen, and Schill. J Pers Assess. 1984; 48: 95–7.
- 10Oner N, LeCompte A. State-trait anxiety inventory hand book. Vol 333. Istanbul: Bogazici University Press; 1985. p. 52–6.
- 11Watnick SME. On the frontline of the COVID-19 outbreak: keeping patients on long-term dialysis safe. CJASN. 2020; 15: 710–3.
- 12Wysocki PJ, Kwinta Ł, Potocki P, Konopki K, Streb J, Wojtukiewicz MZ, et al. Systemic treatment of patients with solid tumors during the COVID-19 (SARS-CoV-2) pandemic-comprehensive recommendations of the polish society of clinical oncology. Oncol Clin Pract. 2020; 16(2): 41–51.
- 13Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol. 2020; 21: 629–30.
- 14Lee LY, Cazier JB, Angelis V, Arnold R, Bisht V, Campton NA, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020; 395(10241): 1919–26.
- 15Grivas P, Khaki AR, Wise-Draper TM, French B, Hennessy C, Hsu C. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and cancer consortium. Ann Oncol. 2021; 32(6): 787–800.
- 16Hilbrands LB, Duivenvoorden R, Vart P, Franssen CFM, Hemmelder MH, Jager KJ. COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration. Nephrol Dial Transplant. 2020; 35(11): 1973–83.
- 17Jager KJ, Kramer A, Chesnaye NC, Couchoud C, Sánchez-Álvarez JE, Garneata L. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney Int. 2020; 98(6): 1540–8.
- 18Obispo-Portero B, Cruz-Castellanos P, Jiménez-Fonseca P, Rogado J, Hernandez R, Castillo-Trujillo OA, et al. Anxiety and depression in patients with advanced cancer during the COVID-19 pandemic. Support Care Cancer. 2021; 30(4): 3363–70.
- 19Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, et al. Stress and symptom burden in oncology patients during the COVID-19 pandemic. J Pain Symptom Manage. 2020; 60(5): 25–34.
- 20Letaief-Ksontini F, Zenzri Y, Yahyaoui Y, Gabsi A, Mokrani A, Meddeb K, et al. 1573P anxiety and depression in cancer patients during the COVID-19 pandemic: a single-centre study. Ann Oncol. 2020; 31: 957–8.
- 21Hao W, Tang Q, Huang X, Ao L, Wang J, Xie D. Analysis of the prevalence and influencing factors of depression and anxiety among maintenance dialysis patients during the COVID-19 pandemic. Int Urol Nephrol. 2020; 53(7): 1453–61.
- 22Zhang S, Zhong Y, Wang L, Yin X, Li Y, Liu Y, et al. Anxiety, home blood pressure monitoring, and cardiovascular events among older hypertension patients during the COVID-19 pandemic. Hypertens Res. 2022; 45(5): 856–65.
- 23Sayed Ahmed HA, Fouad AM, Elotla SF, Joudeh AI, Mostafa M, Shah A, et al. Prevalence and associated factors of diabetes distress, depression and anxiety among primary care patients with type 2 diabetes during the COVID-19 pandemic in Egypt: a cross-sectional study. Front Psychiatry. 2022; 13:937973. https://doi.org/10.3389/fpsyt.2022.937973
- 24Wieteska-Miłek M, Szmit S, Florczyk M, Kuśmierczyk-Droszcz B, Ryczek R, Dzienisiewicz M, et al. Fear of COVID-19, anxiety and depression in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension during the pandemic. J Clin Med. 2021; 10(18):4195. https://doi.org/10.3390/jcm10184195
- 25Burrows AG, Ellis AK. Psychological impacts of coronavirus disease 2019 on people with asthma, allergic rhinitis, and food allergy. Ann Allergy Asthma Immunol. 2022; 129: 52–61.
- 26Udaya Bahadur BC, Pokharel S, Munikar S, Wagle CN, Adhikary P, Shahi BB, et al. Anxiety and depression among people living in quarantine centers during COVID-19 pandemic: a mixed method study from western Nepal. PLoS One. 2021; 16(7):e0254126. https://doi.org/10.1371/journal.pone.0254126
- 27Xiong J, Lipsitz O, Nasri F, Lui LMW, Gill H, Phan L, et al. Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J Affect Disord. 2020; 277: 55–64.
- 28Frey MK, Ellis AE, Zeligs K, Chapman-Davis E, Thomas C, Christos PJ, et al. Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer. Am J Obstet Gynecol. 2020; 223(5): 725.e1–9. https://doi.org/10.1016/j.ajog.2020.06.049
- 29Rodler S, Apfelbeck M, Schulz GB, Ivanova T, Buchner A, Staehler M, et al. Telehealth in uro-oncology beyond the pandemic: toll or lifesaver? Eur Urol Focus. 2020; 6(5): 1097–103.
- 30Yang S, Dong D, Gu H, Gale RP, Ma J, Huang X. Impact of stopping therapy during the SARS-CoV-2 pandemic in persons with lymphoma. J Cancer Res Clin Oncol. 2020; 147(5): 1469–79.
- 31Alagoz S, Eren N, Ozcan SG, Atlı Z, Ozkul O, Belli H, et al. Impact of COVID-19 lockdown on mood status: a comparison of hemodialysis and oncology patients. Ther Apher Dial. 2021; 26: 781–9. https://doi.org/10.1111/1744-9987.13767
- 32Pérez-San-Gregorio MA, Martín-Rodríguez A, Borda-Mas M, Avargues-Navarro ML, Pérez-Bernal J, Conrad R, et al. Post-traumatic growth and its relationship to quality of life up to 9 years after liver transplantation: a cross-sectional study in Spain. BMJ Open. 2017; 7(9):e017455.
